As therapeutics become more personalized and targeted, technology, such as open-source software, can help companies innovate.
Greg Killian
Advertisement
Articles by Greg Killian
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing
2
FDA Approves Tecentriq for Stage III dMMR Colon Cancer
3
Viatris Acquires Pacira BioSciences for $1.65 Billion
4
Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Enters Global License Agreement with Genentech
5